STRUCTURE-BASED DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF IRREVERSIBLE HUMAN RHINOVIRUS 3C PROTEASE INHIBITORS - 1 - MICHAEL ACCEPTORSTRUCTURE-ACTIVITY STUDIES

Citation
Ps. Dragovich et al., STRUCTURE-BASED DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF IRREVERSIBLE HUMAN RHINOVIRUS 3C PROTEASE INHIBITORS - 1 - MICHAEL ACCEPTORSTRUCTURE-ACTIVITY STUDIES, Journal of medicinal chemistry, 41(15), 1998, pp. 2806-2818
Citations number
71
Categorie Soggetti
Chemistry Medicinal
ISSN journal
00222623
Volume
41
Issue
15
Year of publication
1998
Pages
2806 - 2818
Database
ISI
SICI code
0022-2623(1998)41:15<2806:SDSABE>2.0.ZU;2-5
Abstract
The structure-based design, chemical synthesis, and biological evaluat ion of peptide-derived human rhinovirus (HRV) 3C protease (3CP) inhibi tors are described. These compounds incorporate various Michael accept or moieties and are shown to irreversibly bind to HRV serotype 14 3CP with inhibition activities (k(obs)/[I]) ranging from 100 to 600 000 M- 1 s(-1). These inhibitors are also shown to exhibit antiviral activity when tested against HRV-14-infected H1-HeLa cells with EC50's approac hing 0.50 mu M. Extensive structure-activity relationships developed b y Michael acceptor alteration are reported along with the evaluation o f several compounds against HRV serotypes other than 14. A 2.0 Angstro m crystal structure of a peptide-derived inhibitor complexed with HRV- 2 3CP is also detailed.